1. Home
  2.  » 
  3. About Us
  4.  » Our Leadership

Our Leadership

Catalent has attracted a world-class array of strategic and operational talent to lead us into cutting-edge innovation and reliable supply for our customers. Meet our Biologics and Gene Therapy Senior Leadership Teams below.

Biologics Leadership

KAREN FLYNN

President, Biologics &
Chief Commercial Officer

MIKE RILEY

Region President,
Biologics,
North America

MARIO GARGIULO

Region President,
Biologics, Europe

VIC VINCI, PH.D.

Vice President, Product Development

SCOTT GUNTHER

Interim Vice President,
Quality, Biologics
Senior Vice President of Quality & Regulatory Affairs

THOMAS CASTELLANO

Global Vice President,
Operational Finance

GREG BLECK, PH.D.

Global Head of R&D, Biologics

BARBARA SAMBUCO

General Manager,
Anagni

DENIS JOHNSON

Vice President /
General Manager,
Bloomington

GRAHAM BREARLEY, PH.D.

General Manager,
Madison

WIM BLENDEMAN

General Manager,
Brussels

JASON SPACEK

Vice President,
Commercial Operations,
North America

ANDREA COMO

Vice President,
Commercial Operations,
Europe

LISA KRALLIS

Vice President,
Business Development, Drug Substance & Analytical,
North America

MARC GOEMANS

Vice President,
Business Development,
Europe

BERNIE CLARK

Vice President,
Marketing & Strategy

MARIA VIRGINIA POLI

Associate
General Counsel

REKHA PATEL

Director, Biologics Analytical Solutions

YUNSONG (FRANK) LI, PH.D.

Senior Director,
Product Development

Cell & Gene Therapy Leadership

Biologics Advisory Board

Redwood Scientific Advisory Board